Search Results - Huub Schellekens
- Showing 1 - 20 results of 28
- Go to Next Page
-
1
Biosimilar therapeutics--what do we need to consider? by Huub Schellekens
Published 2008Artigo -
2
Immunogenicity of therapeutic proteins by Huub Schellekens
Published 2003Revisão -
3
Factors influencing the immunogenicity of therapeutic proteins by Huub Schellekens
Published 2005Revisão -
4
Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies by Erik Doevendans, Huub Schellekens
Published 2019Revisão -
5
-
6
Immunogenicity of biopharmaceuticals by M. Kessler, David Goldsmith, Huub Schellekens
Published 2006Revisão -
7
Immunogenicity of Therapeutic Proteins: The Use of Animal Models by Vera Brinks, Wim Jiskoot, Huub Schellekens
Published 2011Revisão -
8
-
9
Safety and efficacy of biosimilars in oncology by Huub Schellekens, Josef S Smolen, Mario Dicato, Robert M. Rifkin
Published 2016Revisão -
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
Search Tools:
Related Subjects
Biology
Immunology
Medicine
Biochemistry
Immunogenicity
Internal medicine
Antibody
Immune system
Virology
Chemistry
Gene
Biosimilar
Molecular biology
Pharmacology
Computer science
Programming language
Recombinant DNA
Virus
Biotechnology
Computational biology
Genetics
In vitro
Intensive care medicine
Interchangeability
Monoclonal antibody
Risk analysis (engineering)
Bone marrow
Epitope
Epoetin alfa
Erythropoietin